← Browse by Condition
Medical Condition
ovarian neoplasms
Total Trials
7
Recruiting Now
7
Trial Phases
Phase 1, Phase 2, Phase 2, Phase 2, Phase 3
NCT06819215 Phase 1, Phase 2
Recruiting
Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors
Enrollment
188 pts
Location
China
Sponsor
Zhejiang Yangli Pharmaceutical...
NCT05610501
Recruiting
Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses.
Enrollment
200 pts
Location
Belgium, Czechia, It...
Sponsor
Universitaire Ziekenhuizen KU ...
NCT04519151 Phase 2
Recruiting
Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer
Enrollment
24 pts
Location
Israel
Sponsor
Sheba Medical Center
NCT05768178 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
Enrollment
30 pts
Location
United Kingdom
Sponsor
Cancer Research UK
NCT04641247 Phase 2
Recruiting
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Enrollment
30 pts
Location
United States, Austr...
Sponsor
GlaxoSmithKline
NCT06380816 Phase 1, Phase 2
Recruiting
A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
Enrollment
167 pts
Location
United Kingdom
Sponsor
Cancer Research UK
NCT06023862 Phase 2
Recruiting
A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)
Enrollment
198 pts
Location
Japan, Singapore, So...
Sponsor
Yonsei University